DR. JOHN JOSEPH NEMUNAITIS, MD
Osteopathic Medicine at Worth St, Dallas, TX
License number
Texas J3859
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
3410 Worth St, Dallas, TX 75246
Phone
(214) 370-1870
(214) 370-1860 (Fax)
(972) 997-8000
(972) 437-9605 (Fax)
(214) 370-1860 (Fax)
(972) 997-8000
(972) 437-9605 (Fax)
Personal information
See more information about JOHN JOSEPH NEMUNAITIS at radaris.comName
Address
Phone
1136 Mallard Pointe Dr, Cedar Hill, TX 75104
256 E Corporate Dr APT 1711, Lewisville, TX 75067
1136 Mallard Pointe Dr, Cedar Hill, TX 75104
3535 Worth St, Dallas, TX 75246
9191 Garland Ave, Dallas, TX 75218
Professional information
John Joseph Nemunaitis, Dallas TX
Specialties:
Oncologist
Address:
3535 Worth St, Dallas, TX 75246
Education:
Case Western Reserve University, School of Medicine - Doctor of Medicine
Boston Medical Center - Residency - Internal Medicine
Boston Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
John Joseph Nemunaitis, Dallas TX
Specialties:
Internal Medicine, Hematology & Oncology, Hematology, Medical Oncology, Physical Medicine & Rehabilitation
Work:
Texas Oncology
3535 Worth St, Dallas, TX 75246 Texas Oncology
3310 Live Oak St, Dallas, TX 75204
3535 Worth St, Dallas, TX 75246 Texas Oncology
3310 Live Oak St, Dallas, TX 75204
Education:
Case Western Reserve University(1982)
Dr. John J Nemunaitis, Dallas TX - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Mary Carly Cancer Research
3535 Worth St, Dallas 75246
(214) 370-1870 (Phone)
3535 Worth St, Dallas 75246
(214) 370-1870 (Phone)
Certifications:
Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Case Western Reserve University School Of Medicine
Boston City Hospital
University Wa Med Center
Fred Hutchenson Canc Rsch C
Case Western Reserve University School Of Medicine
Boston City Hospital
University Wa Med Center
Fred Hutchenson Canc Rsch C
Anti-Tumor Activity Of An Oncolytic Adenovirus-Delivered Oncogene Sirna
US Patent:
2007025, Nov 8, 2007
Filed:
May 4, 2007
Appl. No.:
11/744236
Inventors:
Alex W. Tong - Dallas TX, US
Yu An Zhang - Plano TX, US
John J. Nemunaitis - Dallas TX, US
Yuqiao Shen - Orinda CA, US
Po-hsun Chen - Addison TX, US
Shirley K. Samuel - Irving TX, US
Yu An Zhang - Plano TX, US
John J. Nemunaitis - Dallas TX, US
Yuqiao Shen - Orinda CA, US
Po-hsun Chen - Addison TX, US
Shirley K. Samuel - Irving TX, US
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
MUREX PHARMACEUTICALS - Dallas TX
BAYLOR UNIVERSITY - Waco TX
MUREX PHARMACEUTICALS - Dallas TX
BAYLOR UNIVERSITY - Waco TX
International Classification:
A61K 48/00, C12N 15/861
US Classification:
424 932, 435456
Abstract:
The present invention includes compositions and methods for the knockdown of one or more genes to a target cell in need of gene therapy by using an siRNA transgene that is integrated into a replication-competent, oncolytic adenovirus.